Results of Routine Retreatment for Pulmonary Tuberculosis at Health Centres

Hong, Young Pyo; Chang, Sung Chil

doi:1982.29.1.11

Tuberc Respir Dis > Volume 29(1); 1982 > Article

Original Article

Tuberculosis and Respiratory Diseases 1982;29(1):11-21.
DOI: https://doi.org/10.4046/trd.1982.29.1.11 Published online March 1, 1982.

Results of Routine Retreatment for Pulmonary Tuberculosis at Health Centres

Young Pyo Hong, Sung Chil Chang

The Korean National Tuberculosis Association, Korean Institute of Tuberculosis, Seoul, Korea

보건소에 있어서의 폐결핵 통상 재 치료 성적

홍영표, 장승칠

Abstract

The results of routine retreatment for pulmonary tuberculosis at Health Centres were assessed in patients who have failed to first line chemotherapy. Out of 214 Health Centres, 51 Centres were selected randomly. 1033 patients have registered and treated at above mentioned 51 Centres from 1 December 78 through 30 November 79. For the purpose of detailed assessment, patients were chosen who have registered to retreatment in December 78, March, June, and September 1979 respectively. Thus, 330 patients became the subjects of present analyses. The regimens were: ERZ ethambutol (12 months) plus rifampicin(12 months) plus pyrazinamide (12 months); EZK ethambutol(24 months) plus pyr.azinamide(12 months) plus kanamycin(6 months); RZK rifampicin (12 months) plus pyrazinamide (12 months) plus kanamycin(6 months); and ERK ethambutol (12 months) plus rifampicin (12 months) plus kanamycin(6 months). As assessed at 12 months, a bacteriologically favourable response was achieved in 104(87%) of 120 ERZ, 12(63%) of 19 EZK, 60(71%) of 84 RZK, and 21(88%) of 24 ERK in patients with pretreatment sensitivity to relevant drugs. The untoward reactions were not significant. The premature departure from the retreatment was 19% during one year of treatment, which was lower than that of the routine initial treatment at Health Centres.

TOOLS

PDF Links
Full text via DOI
Download Citation
Share :

METRICS

0 Crossref
Scopus
3,463 View
13 Download

Related articles

Relapases in Pulmonary Tubersulosis

Some Opinions on the Recent Trencls of Treatment & Control of Pulmonary Tuberculosis in Korea

Prednisolone in The Treatment of Pulmonary Tuberculosis

On Operative Treatment of Cavernous Tuberculosis of the Lung

Surgical Treatment in Pulmonary Tuberculosis

ABOUT

ARTICLE & TOPICS

Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org